English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Feb 8, 2016

Obama calls for $1 billion in funding for National Cancer Moonshot initiative
+ Technology/Innovation
Jamie Barrand | Feb 7, 2016

Merck's Emend therapy approved for treatment of nausea, vomiting in chemotherapy patients
+ Technology/Innovation
Jamie Barrand | Feb 7, 2016

FDA to review Shire's second New Drug Application for dry eye therapy
+ Technology/Innovation
Jamie Barrand | Feb 7, 2016

Mersana, Takeda partner on tumor therapy development
+ Technology/Innovation
Jamie Barrand | Feb 5, 2016

Mind Your Risks campaign addresses link between high blood pressure, decreased brain function
+ Technology/Innovation
Jamie Barrand | Feb 5, 2016

Spiriva Respimat approved in U.S. for asthma maintenance
+ Technology/Innovation
Kasey Schefflin- Emrich | Feb 5, 2016

AbbVie's venetoclax cancer treatment receives FDA Breakthrough Therapy Designation
+ Technology/Innovation
Jamie Barrand | Feb 5, 2016

CDC releases 2016 vaccination schedules for adults, children

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes